scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0272-5231(05)70263-X |
P698 | PubMed publication ID | 10907585 |
P2093 | author name string | Hamid QA | |
Minshall EM | |||
Muro S | |||
P2860 | cites work | Differences in mediator release between allergic rhinitis and asthma | Q70136486 |
The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils and their progenitors | Q70260029 | ||
Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease | Q70503331 | ||
Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics | Q70523636 | ||
Cationic proteins alter smooth muscle function by an epithelium-dependent mechanism | Q70769536 | ||
Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa | Q70906154 | ||
Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein | Q70911250 | ||
Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro | Q24601699 | ||
Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines | Q24670321 | ||
Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion | Q24680147 | ||
Increased Expression of Interleukin-16 in Bronchial Mucosa of Subjects with Atopic Asthma | Q28247248 | ||
Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines | Q28253247 | ||
IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2 | Q33648586 | ||
Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness | Q33665320 | ||
Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor | Q33894905 | ||
Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates | Q34185442 | ||
Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells | Q34244537 | ||
Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. | Q34488206 | ||
Human monocyte-derived mucus secretagogue | Q34523890 | ||
Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract | Q34612311 | ||
Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. | Q34740323 | ||
Expression of growth factors and remodelling of the airway wall in bronchial asthma | Q35563890 | ||
Direct evidence of a role for mast cells in the pathogenesis of antigen-induced bronchoconstriction | Q35582393 | ||
Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils | Q36230348 | ||
Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. | Q36261169 | ||
Activated mast cells produce interleukin 13. | Q36364660 | ||
Immunologic and neuropharmacologic stimulation of mucous glycoprotein release from human airways in vitro | Q37026884 | ||
In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs | Q37352160 | ||
Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction | Q37362201 | ||
Mast cells as a source of multifunctional cytokines | Q37781952 | ||
The eosinophil and the pathophysiology of asthma | Q39730322 | ||
Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions | Q39761202 | ||
Basophil and eosinophil differentiation in allergic reactions | Q40395762 | ||
Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. | Q40768651 | ||
Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases | Q40773752 | ||
Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. | Q40791336 | ||
Synthetic functions of airway smooth muscle in asthma | Q40885496 | ||
Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes | Q41020266 | ||
Human mast cell cytokines. | Q41098206 | ||
The expanding universe of T-cell subsets: Th1, Th2 and more. | Q41120396 | ||
Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to | Q41166399 | ||
Synthesis of type 1 (IFN gamma) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils | Q41200709 | ||
A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema | Q41203389 | ||
The pathology of asthma, with special reference to changes in the bronchial mucosa | Q41286069 | ||
Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate | Q41850805 | ||
Expression of the Potent Inflammatory Cytokines, GM-CSF, IL6, and IL8, in Bronchial Epithelial Cells of Asthmatic Patients | Q42081697 | ||
Histamine release from bronchoalveolar lavage cells from asthmatic subjects after allergen challenge and relationship to the late asthmatic response | Q42452598 | ||
Expression of CD44 isoforms is increased in the airway epithelium of asthmatic subjects | Q42528813 | ||
Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi | Q44147271 | ||
Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. | Q44293361 | ||
Chronic cough: eosinophilic bronchitis without asthma | Q44412316 | ||
TNFalpha mRNA expression in allergic inflammation | Q44601210 | ||
Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma | Q44995246 | ||
Modulation of growth and differentiation of eosinophils from human peripheral blood CD34+ cells by IL5 and other growth factors | Q45001771 | ||
Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies | Q45024776 | ||
Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity | Q45055229 | ||
Early changes in T lymphocytes recovered by bronchoalveolar lavage after local allergen challenge of asthmatic airways | Q45200131 | ||
Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge | Q45402860 | ||
Platelet-activating Factor Induces Goblet Cell Hyperplasia and Mucin Gene Expression in Airways | Q46715154 | ||
Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin | Q46786632 | ||
Activation of guinea pig lymphocytes and mast cells by grain-dust extract | Q46793576 | ||
Expression of Epidermal Growth Factor and Epidermal Growth Factor Receptor Immunoreactivity in the Asthmatic Human Airway | Q47991162 | ||
Inflammatory and Structural Changes in the Small Airways in Bronchial Asthma | Q48028134 | ||
Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects | Q49280491 | ||
Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: Relationship to methacholine responsiveness☆☆☆★ | Q50527731 | ||
Accumulation of basophils and their chemotactic activity in the airways during natural airway narrowing in asthmatic individuals | Q50768793 | ||
Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis. | Q51085651 | ||
Airway mucosal inflammation even in patients with newly diagnosed asthma | Q51670975 | ||
Ciliated cell damage in the bronchial epithelium of asthmatics and non-asthmatics | Q52517690 | ||
Direct Assessment of Small Airways Reactivity in Human Subjects | Q54146490 | ||
O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans | Q54430630 | ||
SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS | Q57786432 | ||
Expression of IL-4, Cϵ RNA, and Iϵ RNA in the nasal mucosa of patients with seasonal rhinitis: Effect of topical corticosteroids | Q58428812 | ||
Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores | Q59052484 | ||
Expression of the IL-4 receptor α-subunit is increased in bronchial biopsy specimens from atopic and nonatopic asthmatic subjects | Q61895265 | ||
Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and I | Q61895275 | ||
Membrane-bound and soluble alpha IL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics | Q61895277 | ||
Upregulation of αGM-CSF-receptor in nonatopic asthma but not in atopic asthma | Q61895280 | ||
High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma | Q61895283 | ||
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity | Q61895285 | ||
Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma | Q61895286 | ||
Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation | Q61960815 | ||
Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma | Q67534832 | ||
Late-phase Asthmatic Reaction to Inhaled Allergen Is Associated with Early Recruitment of Eosinophils in the Airways | Q67924535 | ||
Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness | Q67995669 | ||
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma | Q68052191 | ||
Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack | Q68084501 | ||
Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure | Q68101083 | ||
T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis | Q68139847 | ||
Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects | Q68178635 | ||
Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors | Q68189016 | ||
Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage | Q68199984 | ||
A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial | Q68204917 | ||
Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry | Q68574133 | ||
Myofibroblasts and subepithelial fibrosis in bronchial asthma | Q68576490 | ||
Chronic eosinophilic pneumonia. Evidence for eosinophil degranulation and release of major basic protein | Q68858021 | ||
Donor sensitivity to basophil activation by eosinophil granule major basic protein | Q68934306 | ||
Cellular and protein changes in bronchial lavage fluid after late asthmatic reaction in patients with red cedar asthma | Q69062332 | ||
Inflammatory mediators in late antigen-induced rhinitis | Q69383879 | ||
T lymphocyte activation in acute severe asthma | Q69917958 | ||
Cellular events in the bronchi in mild asthma and after bronchial provocation | Q69960302 | ||
Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cells in asthma. Relative increases in OKT8 cells in single early responders compared with those in late-phase responders | Q70037295 | ||
Immunoglobulin G subclass proteins in serum and lavage fluid of normal subjects. Quantitation and comparison with immunoglobulins A and E | Q70102896 | ||
Damage of the airway epithelium and bronchial reactivity in patients with asthma | Q70102904 | ||
Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients | Q71046247 | ||
Increased interleukin-10 messenger RNA expression in atopic allergy and asthma | Q71078172 | ||
Airway structure and inflammatory cells in fatal attacks of asthma | Q71312009 | ||
Airway muscle stereology: implications for increased shortening in asthma | Q71540473 | ||
Elevation of serum soluble tumour necrosis factor (TNF) receptor and IL-1 receptor antagonist levels in bronchial asthma | Q71685431 | ||
Expression of interleukin-1 beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium | Q71718471 | ||
Evidence for major basic protein immunoreactivity and interleukin 5 gene activation during the late phase response in explanted airways | Q71778405 | ||
Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects | Q71778422 | ||
Expression of RANTES mRNA and protein in airways of patients with mild asthma | Q71907032 | ||
CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy | Q72212029 | ||
Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects | Q72247946 | ||
Allergen-induced recruitment of inflammatory cells in lavage 3 and 24 h after challenge in allergic asthmatic lungs | Q72300595 | ||
Small airways dimensions in asthma and in chronic obstructive pulmonary disease | Q72604870 | ||
Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma | Q72668626 | ||
Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation | Q72785403 | ||
Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression | Q72860726 | ||
Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma | Q72876327 | ||
Are hypodense eosinophils in children activated or immature? | Q72885359 | ||
Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma | Q72900769 | ||
Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? | Q72918047 | ||
Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study | Q72918050 | ||
The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics | Q73094054 | ||
Airway epithelium expresses interleukin-18 | Q73136715 | ||
Airways remodeling is a distinctive feature of asthma and is related to severity of disease | Q73231629 | ||
Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy | Q73263336 | ||
Bronchial Subepithelial Fibrosis Correlates With Airway Responsiveness to Methacholine | Q73521531 | ||
Inflammation of small airways in asthma | Q73588484 | ||
Transforming Growth Factor- β Expression in Mucosal Biopsies in Asthma and Chronic Bronchitis | Q73651422 | ||
Eosinophil-associated TGF- β1mRNA Expression and Airways Fibrosis in Bronchial Asthma | Q73728083 | ||
Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids | Q73730745 | ||
Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics | Q73734199 | ||
Release of RANTES, MIP-1 α , and MCP-1 into Asthmatic Airways Following Endobronchial Allergen Challenge | Q73885831 | ||
Changes in Bone Marrow Inflammatory Cell Progenitors after Inhaled Allergen in Asthmatic Subjects | Q74100380 | ||
Expression and Release of Interleukin-8 by Human Airway Smooth Muscle Cells: Inhibition by Th-2 Cytokines and Corticosteroids | Q74111175 | ||
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells | Q74179405 | ||
Bronchial Neutrophilia in Patients with Noninfectious Status Asthmaticus | Q74225372 | ||
Cytokine mRNA expression in asthma is not restricted to the large airways | Q74391022 | ||
Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals | Q74590630 | ||
Interleukin-5 Expression in the Bone Marrow of Sensitized Balb/c Mice after Allergen Challenge | Q77218157 | ||
Cultured human airway smooth muscle cells stimulated by interleukin-1beta enhance eosinophil survival | Q77650034 | ||
CD34(+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors | Q77742474 | ||
Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells | Q77822572 | ||
Enhanced proteoglycan deposition in the airway wall of atopic asthmatics | Q78077660 | ||
Causes of death and pathologic findings in 304 cases of bronchial asthma | Q79073338 | ||
Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions | Q93630485 | ||
Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma | Q93864366 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | asthma | Q35869 |
P304 | page(s) | 225-244 | |
P577 | publication date | 2000-06-01 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Clinics in Chest Medicine | Q15754921 |
P1476 | title | The pathology of chronic asthma | |
P478 | volume | 21 |
Q37285975 | Asthma: where is it going? |
Q44595397 | Blunted Cortisol Responses to Psychosocial Stress in Asthmatic Children: A General Feature of Atopic Disease? |
Q38644301 | IL-25-induced activation of nasal fibroblast and its association with the remodeling of chronic rhinosinusitis with nasal polyposis |
Q44864406 | Increased responsiveness of the hypothalamus-pituitary-adrenal (HPA) axis to stress in newborns with atopic disposition |
Q35070524 | NKT cells in the induced sputum of severe asthmatics |
Q40619966 | Nitric Oxide and Collagen Expression in Allergic Upper-Airway Disease |
Q34572155 | Role of chemokines in the pathogenesis of asthma |
Q37392523 | T cell homing to epithelial barriers in allergic disease |
Q28191630 | The role of mast cells in asthma |
Q37755301 | Tryptase as an inflammatory marker in allergic disease and asthma |
Search more.